Valneva SE was granted emergency use authorization by the National Health Regulatory Authority (NHRA) of the Kingdom of Bahrain for its inactivated, adjuvanted COVID-19 vaccine, VLA2001. This authorization follows a rolling review process with the Bahraini NHRA and reflects the NHRA’s initiative to support the authorization of COVID-19 vaccines. 
  Valneva signed an advance purchase agreement with the Kingdom of Bahrain in December 2021 for the supply of one million doses of VLA2001. The Compa...